icone plus
Contact Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
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
f9sjuQf2f3UBKFxG
Listen
